State Street Corp Gbs Inc. Transaction History

State Street Corp

  • $2.25 Trillion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023
SELL
N/A
-34,115 Closed
0 $0
Q2 2022

Aug 15, 2022
BUY
$0.56 - $1.31 $13,216 - $30,916
23,600 Added 224.44%
34,115 $23,000
Q1 2022

May 16, 2022
BUY
$0.43 - $1.7 $4,521 - $17,875
10,515 New
10,515 $8,000

Others Institutions Holding GBS

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0
View Full List

About GBS Inc.

GBS Quotes by TradingView
  • Ticker GBS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 14,889,900
  • Description
  • GBS Inc. operates as a biosensor diagnostic technology company. It offers Saliva Glucose Biosensor that uses saliva to measure glucose non-invasively. The company also focuses on developing COV2 test, a biosensor test can be used as a complement to the (RNA) virus detection test; and a biosensor platform comprising of biochemistry, immunology, t...
More about GBS
Track This Portfolio

Track State Street Corp Portfolio

Follow State Street Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email